Refine by
Infusion Pump System Articles & Analysis
18 news found
Flowonix Medical Inc. of New Jersey, and Colorado-based Cerebral Therapeutics, announced today the first patients implanted with the Prometra II Programmable Infusion System in the Australian Direct Drug Administration for Refractory Epilepsy (ADDRESS) clinical trial at St. ...
Each technology will showcase how it improves clinical outcomes, enhances safety or drives incremental improvements to health care delivery or business models. The Ivenix Infusion System from Fresenius Kabi is a large volume infusion pump supported by a management system specifically designed to simplify each ...
Following the announced closing of the acquisition of Ivenix and its advanced infusion pump technology, Fresenius Kabi now offers healthcare professionals a broad and expanding portfolio of advanced infusion pumps and solutions to meet health care needs across the continuum of care. ...
Deborah Heart and Lung Center announces its successful hospital-wide go live with Ivenix, a modern smart infusion pump system. “Though everyone is familiar with IV pump delivery systems used to administer medications during a patient’s hospital stay, improvements in technology have allowed us to do ...
BioQ Pharma Incorporated (“the Company”), a specialty pharmaceutical company, today announced receipt of CE mark approval in the European Union for its OneDose ReadyfusOR Gen2, single-use medication dispenser. The OneDose ReadyfusOR Gen2 is the second generation of the Company’s original OneDose ReadyfusOR infusion system and was developed to further improve patient convenience. ...
About Ivenix Ivenix, Inc. is a medical technology company with a vision to eliminate infusion-related patient harm. The company was founded to develop innovative solutions that transform infusion delivery. Ivenix designed an infusion system from the ground up to streamline medication delivery and bring legacy technology into the ...
Flowonix Medical, Inc. today announced United States Food and Drug Administration (FDA) approval to market the Prometra II Programmable Pump System for use with intrathecal baclofen. Flowonix introduced the Prometra II 40mL pump to the US market in November 2019, providing patients and clinicians a choice between 20 mL and 40 mL capacities when ...
BioQ Pharma Incorporated (“the Company”), a specialty pharmaceutical company, today announced that Dr. Marijn Dekkers has agreed to join the Company’s board of directors. Dr. Dekkers is founder and chairman of Novalis LifeSciences, an investment and advisory firm for the life science industry. He served as CEO of Bayer AG, a global life sciences company, from 2010 to 2016 and ...
BioQ Pharma Incorporated, a specialty pharmaceutical company, today announced that it has entered into a Development, Supply, Distribution Agreement with Avanos Medical, Inc. (NYSE: AVNS, “Avanos”). Under the agreement, the parties will work together to obtain appropriate regulatory approvals and commercialize self-contained, infusible, non-opioid post-operative pain pharmaceutical ...
BioQ Pharma Incorporated (“the Company”), a specialty pharmaceutical company, today announced that the Australian Therapeutic Goods Administration (TGA) has approved the Company’s Propofusor product containing 1% propofol in a single-use dispensing system. Uses of the Propofusor include the induction and maintenance of general anesthesia, sedation of mechanically ventilated ...
Flowonix Medical, Inc. today announced United States Food and Drug Administration (FDA) approval to market the Flowonix Maestro™ Software for Clinician Programmers used to program Prometra® Pump Systems. The new software is designed to improve the user experience for both clinicians and patients. ...
BioQ Pharma Incorporated (“the Company”), a specialty pharmaceutical company focused on developing and commercializing ready-to-use infusible pharmaceuticals, today announced the positive closure of a European regulatory procedure for its propofol product. The Company’s ready-to-use infusion pharmaceutical includes the propofol drug product and delivery system in a single-use ...
BioQ Pharma Incorporated, a specialty pharmaceutical company, announced today that the Company will be presenting at the 38th Annual Canaccord Genuity Growth Conference to be held in Boston Massachusetts on August 8th and 9th, 2018. Josh Kriesel, President and Chief Executive Officer, is scheduled to present on Wednesday, August 8th at 12:30 p.m. Eastern Daylight Time. About BioQ Pharma BioQ ...
BioQ Pharma Incorporated (“the Company”), a specialty pharmaceutical company, today announced that Dr. Marijn Dekkers has become a strategic advisor to the Company. Concurrent, with his advisory role, Dr. Dekkers also made an investment in BioQ Pharma through his advisory and investment vehicle Novalis LifeScience LLC. Dr. Dekkers is currently the Chairman of Unilever and the Founder ...
The ProView platform also introduces the Inquiry Summary Report, which is the first programming summary report on the market to provide initial and final pump settings side by side on one report with changes highlighted and bolded for easier identification. ...
The jointly developed therapy features a micro-infusion device which tightly controls drug delivery to a region of the brain for patients with medically refractory epilepsy. ...
Fortrans Inc. announces new patent pending technology to mix gases into water and other media. The Dif-JET System is non-fouling and does not depend on bubble technology to mix gases into water. DiF-JET single and combination Gas Infusion Systems are highly efficient at mixing beneficial gases such as oxygen, carbon dioxide, nitrogen and air into water or other media. DiF-JET inline non-fouling ...
Gas inFusion technologies developed by inVentures include passive and active systems for transferring dissolved gasses to groundwater, surface water, and wastewater. The iSOC/HiSOC systems are employed in passive treatment wells for delivering oxygen, hydrogen, and cometabolic gas substrates to aid in bioremediation. In comparison, inFusion gPRO systems are used for the same applications, but ...